Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9AL02
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 12 |
GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 3 | 12 |
GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 4 | 12 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043169 | cation binding | 3 | 11 |
GO:0046872 | metal ion binding | 4 | 11 |
GO:0051213 | dioxygenase activity | 3 | 12 |
GO:0047800 | cysteamine dioxygenase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 200 | 204 | PF00656 | 0.431 |
CLV_C14_Caspase3-7 | 56 | 60 | PF00656 | 0.539 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.162 |
CLV_PCSK_FUR_1 | 21 | 25 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.540 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.227 |
CLV_PCSK_PC1ET2_1 | 23 | 25 | PF00082 | 0.438 |
CLV_PCSK_PC7_1 | 19 | 25 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.416 |
DEG_APCC_DBOX_1 | 148 | 156 | PF00400 | 0.457 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.474 |
DOC_CYCLIN_RxL_1 | 126 | 135 | PF00134 | 0.491 |
DOC_PP4_FxxP_1 | 123 | 126 | PF00568 | 0.448 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.472 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.551 |
DOC_USP7_UBL2_3 | 23 | 27 | PF12436 | 0.542 |
DOC_USP7_UBL2_3 | 268 | 272 | PF12436 | 0.491 |
DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.579 |
DOC_WW_Pin1_4 | 195 | 200 | PF00397 | 0.561 |
DOC_WW_Pin1_4 | 224 | 229 | PF00397 | 0.461 |
DOC_WW_Pin1_4 | 92 | 97 | PF00397 | 0.545 |
LIG_14-3-3_CanoR_1 | 24 | 30 | PF00244 | 0.517 |
LIG_14-3-3_CanoR_1 | 6 | 15 | PF00244 | 0.554 |
LIG_14-3-3_CanoR_1 | 85 | 94 | PF00244 | 0.573 |
LIG_BIR_III_2 | 187 | 191 | PF00653 | 0.457 |
LIG_FHA_1 | 167 | 173 | PF00498 | 0.457 |
LIG_FHA_1 | 248 | 254 | PF00498 | 0.500 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.491 |
LIG_FHA_2 | 196 | 202 | PF00498 | 0.537 |
LIG_FHA_2 | 33 | 39 | PF00498 | 0.528 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.406 |
LIG_LIR_Apic_2 | 279 | 284 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 287 | 293 | PF02991 | 0.260 |
LIG_LIR_Gen_1 | 41 | 51 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 119 | 125 | PF02991 | 0.523 |
LIG_LIR_Nem_3 | 287 | 292 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 50 | 54 | PF02991 | 0.529 |
LIG_MAD2 | 129 | 137 | PF02301 | 0.405 |
LIG_PTB_Apo_2 | 63 | 70 | PF02174 | 0.362 |
LIG_PTB_Phospho_1 | 63 | 69 | PF10480 | 0.362 |
LIG_SH2_CRK | 281 | 285 | PF00017 | 0.480 |
LIG_SH2_NCK_1 | 230 | 234 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.467 |
LIG_SH3_3 | 121 | 127 | PF00018 | 0.480 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.546 |
LIG_TRFH_1 | 123 | 127 | PF08558 | 0.400 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.508 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.515 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.299 |
MOD_CK1_1 | 88 | 94 | PF00069 | 0.420 |
MOD_CK2_1 | 32 | 38 | PF00069 | 0.476 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.544 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.350 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.429 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.745 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.577 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.430 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.395 |
MOD_LATS_1 | 83 | 89 | PF00433 | 0.205 |
MOD_N-GLC_1 | 172 | 177 | PF02516 | 0.350 |
MOD_N-GLC_1 | 279 | 284 | PF02516 | 0.490 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.337 |
MOD_NEK2_1 | 247 | 252 | PF00069 | 0.362 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.501 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.498 |
MOD_NEK2_2 | 108 | 113 | PF00069 | 0.289 |
MOD_NEK2_2 | 14 | 19 | PF00069 | 0.504 |
MOD_PIKK_1 | 158 | 164 | PF00454 | 0.356 |
MOD_PIKK_1 | 214 | 220 | PF00454 | 0.302 |
MOD_PKA_1 | 85 | 91 | PF00069 | 0.169 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.465 |
MOD_Plk_1 | 247 | 253 | PF00069 | 0.303 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.323 |
MOD_Plk_4 | 137 | 143 | PF00069 | 0.285 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.389 |
MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.575 |
MOD_ProDKin_1 | 195 | 201 | PF00069 | 0.447 |
MOD_ProDKin_1 | 224 | 230 | PF00069 | 0.307 |
MOD_ProDKin_1 | 92 | 98 | PF00069 | 0.425 |
TRG_ER_diArg_1 | 19 | 22 | PF00400 | 0.390 |
TRG_ER_diArg_1 | 6 | 9 | PF00400 | 0.549 |
TRG_ER_diArg_1 | 85 | 87 | PF00400 | 0.290 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3C5 | Leptomonas seymouri | 57% | 100% |
A0A0S4IQ52 | Bodo saltans | 30% | 100% |
A0A1X0NH28 | Trypanosomatidae | 40% | 100% |
A0A3S5H5U9 | Leishmania donovani | 89% | 100% |
A0A422NM88 | Trypanosoma rangeli | 32% | 100% |
A4H4T5 | Leishmania braziliensis | 81% | 100% |
A4HT14 | Leishmania infantum | 90% | 100% |
C9ZTQ1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
Q4QIV3 | Leishmania major | 89% | 100% |
V5BT74 | Trypanosoma cruzi | 39% | 100% |